Carmit Nadri-Shay
General Counsel at ADVAXIS, INC.
Carmit Nadri-Shay active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ADVAXIS, INC. | General Counsel | - | - |
| AYALA PHARMACEUTICALS, INC. | General Counsel | 2017-12-31 | - |
Career history of Carmit Nadri-Shay
Former positions of Carmit Nadri-Shay
| Companies | Position | Start | End |
|---|---|---|---|
Protalix Biotherapeutics Ltd.
 Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The private company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | General Counsel | - | - |
| KAMADA LTD. | General Counsel | - | - |
Training of Carmit Nadri-Shay
| Ben-Gurion University of the Negev | Doctorate Degree |
Statistics
International
| Israel | 5 |
| United States | 2 |
Operational
| General Counsel | 4 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| KAMADA LTD. | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Private companies | 2 |
|---|---|
Protalix Biotherapeutics Ltd.
Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The private company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Carmit Nadri-Shay
- Experience
